| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |